MBNL2 and myotonic dystrophy type 1: During a study designed to determine if systemic MBNL2 overexpression in neonatal mice would block disease progression in the HSALR polyCUG model of DM1, we also tested for nonspecific effects of an unrelated RBP, HNRNPA1.